Eli Lilly stock ends 2025 lower as 2026 drug-price shifts and GLP-1 pill race come into focus
NEW YORK, January 1, 2026, 10:21 ET — Market closed
- Eli Lilly shares last closed down 0.5% at $1,074.68 in the final session of 2025. StockAnalysis
- New 2026 pricing data highlighted a more-than-40% list-price cut for Jardiance, which Lilly co-markets. Reuters
- Investors are looking ahead to a January 13 CEO appearance at the J.P. Morgan Healthcare Conference and the company’s Feb. 4 earnings call. Lilly+1
Eli Lilly shares slipped 0.5% in Wednesday’s final session of 2025, closing at $1,074.68, before U.S. markets shut for the New Year’s Day holiday. StockAnalysis+1
Why it matters now: drugmakers typically reset U.S. list prices at the start of the year, and new data have put the industry’s pricing playbook back under a political…
